ArticleFrontiers in oncology2022

A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases.

Ai-Wei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.